Cargando…
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19
PURPOSE: Real-world experience with tocilizumab in combination with dexamethasone in patients with severe coronavirus disease (COVID-19) needs to be investigated. MATERIALS AND METHODS: A retrospective cohort study was conducted to evaluate the effect of severity-adjusted dosing of dexamethasone in...
Autores principales: | Hong, Jin Yeong, Ko, Jae-Hoon, Yang, Jinyoung, Ha, Soyoung, Nham, Eliel, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Chung, Doo Ryeon, Baek, Jin Yang, Sohn, You Min, Park, Hyo Jung, Lee, Beomki, Huh, Hee Jae, Kang, Eun-Suk, Suh, Gee Young, Chung, Chi Ryang, Peck, Kyong Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086692/ https://www.ncbi.nlm.nih.gov/pubmed/35512745 http://dx.doi.org/10.3349/ymj.2022.63.5.430 |
Ejemplares similares
-
Severe Thrombocytopenia in a Patient with COVID-19
por: Nham, Eliel, et al.
Publicado: (2020) -
Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Klebsiella pneumoniae Bacteremia in Cancer Patients
por: Nham, Eliel, et al.
Publicado: (2020) -
1701. Differences in Diagnostic Performance of β-d-Glucan Testing in Patients with Varying Degrees of Susceptibility to Invasive Fungal Infections
por: Nham, Eliel, et al.
Publicado: (2019) -
Effect of short-term corticosteroid use on reactogenicity and immunogenicity of the first dose of ChAdOx1 nCoV-19 vaccine
por: Yang, Jinyoung, et al.
Publicado: (2021) -
Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine
por: Yang, Jinyoung, et al.
Publicado: (2021)